Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Use of N-acetylcysteine during liver procurement: a prospective randomized controlled study.

D'Amico F, Vitale A, Piovan D, Bertacco A, Ramirez Morales R, Chiara Frigo A, Bassi D, Bonsignore P, Gringeri E, Valmasoni M, Garbo G, Lodo E, D'Amico FE, Scopelliti M, Carraro A, Gambato M, Brolese A, Zanus G, Neri D, Cillo U.

Liver Transpl. 2013 Feb;19(2):135-44. doi: 10.1002/lt.23527.

2.

A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.

Selzner M, Kashfi A, Cattral MS, Selzner N, Greig PD, Lilly L, McGilvray ID, Therapondos G, Adcock LE, Ghanekar A, Levy GA, Renner EL, Grant DR.

Liver Transpl. 2009 Dec;15(12):1776-82. doi: 10.1002/lt.21955.

3.

Liver transplantation using suboptimal grafts: impact of donor harvesting technique.

D'Amico F, Vitale A, Gringeri E, Valmasoni M, Carraro A, Brolese A, Zanus G, Boccagni P, D'Amico DF, Cillo U.

Liver Transpl. 2007 Oct;13(10):1444-50.

4.

Impact of reversible cardiac arrest in the brain-dead organ donor on the outcome of adult liver transplantation.

Levesque E, Hoti E, Khalfallah M, Salloum C, Ricca L, Vibert E, Azoulay D.

Liver Transpl. 2011 Oct;17(10):1159-66. doi: 10.1002/lt.22372.

5.

N-acetylcysteine in pig liver transplantation from non-heart-beating donors.

Manika A, Trinh T, Lagacé G, Dugas MA, Proulx F, Lepage G, Champagne J, Lavoie JC, Cousineau J, Russo P, Chartrand C, Yandza T.

Transplantation. 1999 Aug 15;68(3):327-30.

PMID:
10459534
6.

Domino versus deceased donor liver transplantation: association with early graft function and perioperative bleeding.

Bispo M, Marcelino P, Marques HP, Martins A, Perdigoto R, Aguiar MJ, Mourão L, Barroso E.

Liver Transpl. 2011 Mar;17(3):270-8. doi: 10.1002/lt.22210.

7.

Effect of treatment with prostaglandin E1 and N-acetylcysteine on pediatric liver transplant recipients: a single-center study.

Bucuvalas JC, Ryckman FC, Krug S, Alonso MH, Balistreri WF, Kotagal U.

Pediatr Transplant. 2001 Aug;5(4):274-8.

PMID:
11472606
8.

Liver transplantation following donation after cardiac death: an analysis using matched pairs.

Pine JK, Aldouri A, Young AL, Davies MH, Attia M, Toogood GJ, Pollard SG, Lodge JP, Prasad KR.

Liver Transpl. 2009 Sep;15(9):1072-82. doi: 10.1002/lt.21853.

9.

Liver grafts procured by other transplant teams do not affect posttransplantation outcomes.

Salvalaggio PR, Ferraz-Neto BH.

Transplant Proc. 2012 Oct;44(8):2293-6. doi: 10.1016/j.transproceed.2012.07.043.

PMID:
23026577
10.

Sequential versus contemporaneous portal and arterial reperfusion during liver transplantation.

Adani GL, Rossetto A, Lorenzin D, Lugano M, De Anna D, Della Rocca G, Donini A, Bresadola V, Risaliti A, Baccarani U.

Transplant Proc. 2011 May;43(4):1107-9. doi: 10.1016/j.transproceed.2011.01.123.

PMID:
21620064
11.

Comparative prospective study of two liver graft preservation solutions: University of Wisconsin and Celsior.

Lopez-Andujar R, Deusa S, Montalvá E, San Juan F, Moya A, Pareja E, DeJuan M, Berenguer M, Prieto M, Mir J.

Liver Transpl. 2009 Dec;15(12):1709-17. doi: 10.1002/lt.21945.

12.

Safety of blood group A2-to-O liver transplantation: an analysis of the United Network of Organ Sharing database.

Kluger MD, Guarrera JV, Olsen SK, Brown RS Jr, Emond JC, Cherqui D.

Transplantation. 2012 Sep 15;94(5):526-31.

PMID:
22874840
13.

A double-blind, randomized, controlled trial on N-acetylcysteine for the prevention of acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation.

Ataei S, Hadjibabaie M, Moslehi A, Taghizadeh-Ghehi M, Ashouri A, Amini E, Gholami K, Hayatshahi A, Vaezi M, Ghavamzadeh A.

Hematol Oncol. 2015 Jun;33(2):67-74. doi: 10.1002/hon.2141.

PMID:
24711000
14.

Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients.

Ghabril M, Agarwal S, Lacerda M, Chalasani N, Kwo P, Tector AJ.

Transplantation. 2016 Jan;100(1):126-33. doi: 10.1097/TP.0000000000000785.

PMID:
26050013
15.

Effect of N-acetylcysteine pretreatment of deceased organ donors on renal allograft function: a randomized controlled trial.

Orban JC, Quintard H, Cassuto E, Jambou P, Samat-Long C, Ichai C.

Transplantation. 2015 Apr;99(4):746-53. doi: 10.1097/TP.0000000000000395.

16.

Does N-acetylcysteine improve hemodynamics and graft function in liver transplantation?

Steib A, Freys G, Collin F, Launoy A, Mark G, Boudjema K.

Liver Transpl Surg. 1998 Mar;4(2):152-7.

17.

Ischemic Postconditioning of the Liver Graft in Adult Liver Transplantation.

Ricca L, Lemoine A, Cauchy F, Hamelin J, Sebagh M, Esposti DD, Salloum C, Vibert E, Balducci G, Azoulay D.

Transplantation. 2015 Aug;99(8):1633-43. doi: 10.1097/TP.0000000000000685.

PMID:
25856406
18.

Impact of center volume on outcomes of increased-risk liver transplants.

Ozhathil DK, Li YF, Smith JK, Tseng JF, Saidi RF, Bozorgzadeh A, Shah SA.

Liver Transpl. 2011 Oct;17(10):1191-9. doi: 10.1002/lt.22343.

19.

Risk factors in liver retransplantation: a single-center experience.

Crivellin C, De Martin E, Germani G, Gambato M, Senzolo M, Russo FP, Vitale A, Zanus G, Cillo U, Burra P.

Transplant Proc. 2011 May;43(4):1110-3. doi: 10.1016/j.transproceed.2011.01.141.

PMID:
21620065
20.

Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.

Croome KP, Marotta P, Wall WJ, Dale C, Levstik MA, Chandok N, Hernandez-Alejandro R.

Transplant Proc. 2012 Jun;44(5):1303-6. doi: 10.1016/j.transproceed.2012.01.115.

PMID:
22664005
Items per page

Supplemental Content

Support Center